Management challenges in metachronous bilateral breast cancer with discordant receptor status: a case report

1

Bilateral breast cancer accounts for 2%-5% of cases and poses unique clinical challenges, especially with discordant molecular subtypes.
2

The case study involves a 37-year-old woman with metachronous bilateral breast cancer, initially presenting with a left-sided hormone-responsive tumor.
3

The patient later developed a right-sided triple-negative invasive carcinoma, highlighting the complexity of managing tumors with differing receptor profiles.
4

Neoadjuvant chemotherapy was administered to the patient, allowing for tumor downstaging and assessment of chemosensitivity prior to surgery.
5

Multidisciplinary management is crucial for optimizing outcomes in patients with metachronous bilateral breast cancer and discordant receptor status.

1